Arachidonyl Ethanolamide (Anandamide) Activates the Parvocellular Part of Hypothalamic Paraventricular Nucleus
- 28 August 1997
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 237 (3), 724-728
- https://doi.org/10.1006/bbrc.1997.7222
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and ratFEBS Letters, 1996
- Suckling‐Induced Fos‐Immunoreactivity in Subgroups of Hypothalamic POMC Neurons of the Lactating Rat: Investigation of a Role for ProlactinJournal of Neuroendocrinology, 1996
- Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonistLife Sciences, 1995
- Effects of two endogenous fatty acid ethanolamides on mouse vasa deferentiaEuropean Journal of Pharmacology, 1994
- Anandamide, a Brain Endogenous Compound, Interacts Specifically with Cannabinoid Receptors and Inhibits Adenylate CyclaseJournal of Neurochemistry, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Adrenocortical response following acute neurogenic stimuli is mediated by CRF-41Neuroscience Letters, 1989
- Corticosterone and dexamethasone act at different brain sites to inhibit adrenalectomy-induced adrenocorticotropin hypersecretionBrain Research, 1988
- Hypothalamic Control of Adrenocorticotropin Secretion: Advances since the Discovery of 41-Residue Corticotropin-Releasing FactorEndocrine Reviews, 1986
- Corticotrophin and corticosterone secretion following Δ1-tetrahydrocannabinol, in intact and in hypothalamic deafferentated male ratsExperimental Brain Research, 1982